CancerCenterAI was proud to support the practical workshop “Assessment of FOLR1 biomarker expression in ovarian cancer” by providing our digital pathology platform PathoViewer (IMS) for case review and discussion.
The workshop took place on 21–22 May 2026 at Roche Diagnostics Polska in Warsaw and was led by Dr Monika Durzyńska and Prof Łukasz Szylberg
After the theoretical part and the presentation of digital pathology solutions, participants moved to a hands‑o
n session, where they assessed FOLR1 expression in real cases, including challenging and borderline samples, using microscopes, computers and our PathoViewer platform.
PathoViewer enabled synchronized viewing of slides, structured case assessment and interactive discussion, helping to standardize interpretation of FOLR1 staining in ovarian cancer.
For CancerCenterAI, involvement in this workshop is an important milestone showing how advanced digital pathology tools can enhance education, quality and consistency in biomarker diagnostics.
We are glad that PathoViewer contributed to a practical, expert‑driven training focused on clinical context, reporting standards and comparison between LDT assays and the VENTANA CDx test for FOLR1.
Want to see PathoViewer in action? If you are looking for a solution for case presentation, collaborative slide review and support for digital pathology training, PathoViewer (IMS) can help streamline and structure this process. Contact us to schedule a demo and see how PathoViewer can support your team in everyday diagnostic and training workflows.
Contact us